Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock, located in Tehran, is a pharmaceutical company that was established in 1339 A.H. Originally known as Squibb Iran, the company operated under the license of Squibb America and focused on producing cardiovascular, antitussive, and tonic corticosteroid drugs. Following the Iranian Islamic Revolution, multinational companies, including Squibb, were nationalized and brought under the National Industries Organization. As a result, the company was renamed Jaber Ebne Hayyan Pharmaceutical and became a public company in 1370. Currently, Jaber Ebne Hayyan Pharmaceutical Company is a leading producer of injectable and non-injectable antibiotics and respiratory sprays in Iran. The company's success in these areas is attributed to the expertise of its experienced professionals and the use of advanced devices in production.
Headquarters
Km 5 Karaj Special Road, P.O.Box: 13185-1739
Tehran; Tehran;
Postal Code: 13988-34511
Contact Details: Purchase the Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock report to view the information.
Website: http://www.jaber-pharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service